Today: 5 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

US Stock Market Today, December 10, 2025: Wall Street Pauses Near Record Highs Ahead of Fed’s Final Rate Cut of the Year

US Stock Market Today, December 10, 2025: Wall Street Pauses Near Record Highs Ahead of Fed’s Final Rate Cut of the Year

US stock index futures hovered near flat early Wednesday as investors awaited the Federal Reserve’s final interest-rate decision of 2025. On Tuesday, the S&P 500 slipped 0.1% to 6,840.51, the Dow fell 0.4%, and the Nasdaq edged up 0.1%. JPMorgan Chase dropped 4.7% after warning of higher expenses. Treasury yields climbed following strong job openings data.
10 December 2025
··
GE Vernova (GEV) Stock Soars on New 2026 Outlook, Dividend Hike and $10 Billion Buyback

GE Vernova (GEV) Stock Soars on New 2026 Outlook, Dividend Hike and $10 Billion Buyback

GE Vernova shares surged as much as 8% on December 10 after the company raised its 2026 and 2028 financial outlook, doubled its dividend, and expanded its buyback. The stock, now trading near $625, has gained over 85% in 2025 and more than 370% since its March 2024 spin-off. Management cited rising demand from AI, data centers, and grid modernization as key drivers.
10 December 2025
··
Fifth Third–Brex Deal Puts $5.6B AI-Powered Card Platform at Center of Comerica Merger Fight

Fifth Third–Brex Deal Puts $5.6B AI-Powered Card Platform at Center of Comerica Merger Fight

Fifth Third Bank has selected Brex to provide the technology for its commercial card program, covering $5.6 billion in annual payments. The announcement comes as Fifth Third faces lawsuits from HoldCo Asset Management and protests from community groups over its planned $10.9 billion acquisition of Comerica. The deal would create the ninth-largest U.S. bank by assets, pending regulatory approval.
10 December 2025
····
GSK Stock on 10 December 2025: FDA Orphan-Drug Win, New Cancer Deal and What It Means for Investors

GSK Stock on 10 December 2025: FDA Orphan-Drug Win, New Cancer Deal and What It Means for Investors

The US FDA granted Orphan Drug Designation to GSK’s experimental lung cancer therapy risvutatug rezetecan on December 10. GSK shares traded near 1,780 pence in London, up about 29% over 12 months. The drug targets small-cell lung cancer and has shown durable responses in early trials. GSK’s US ADR closed at $47.27, near its 52-week high.
10 December 2025
···
Shell Plc (SHEL) Stock on December 10, 2025: Price, Buybacks, Dividend and 2026 Outlook

Shell Plc (SHEL) Stock on December 10, 2025: Price, Buybacks, Dividend and 2026 Outlook

Shell ADRs traded near $72.55 on the NYSE, close to their 52-week high, while London shares closed at 2,727p on December 10. Shell is in advanced talks to buy LLOG Exploration Offshore for over $3 billion, according to Reuters. The company also temporarily shut output at its Whale and Perdido platforms in the Gulf of Mexico due to a third-party pipeline issue.
10 December 2025
··
Diageo plc Stock Hits 52‑Week Lows: What Belfast Strikes, Profit Warning and a New CEO Mean for DGE/DEO in December 2025

Diageo plc Stock Hits 52‑Week Lows: What Belfast Strikes, Profit Warning and a New CEO Mean for DGE/DEO in December 2025

Diageo shares hit new 52-week lows on both the London and New York exchanges, with DGE closing at 1,602.5p and DEO falling to $85.71 on December 9. Around 90 workers at Diageo’s Belfast packaging site began renewed strike action on December 10 after rejecting a pay offer. The company says Guinness supply will not be disrupted over Christmas. Diageo’s stock is down nearly 30% in 2025.
10 December 2025
··
Rolls-Royce Share Price Today: China JV, 2025 Guidance and 2026–27 Stock Forecast (10 December 2025)

Rolls-Royce Share Price Today: China JV, 2025 Guidance and 2026–27 Stock Forecast (10 December 2025)

Rolls-Royce shares traded near 1,110p on 10 December, nearly doubling year-to-date and lifting market value to about £93 billion. The company opened a new engine overhaul joint venture with Air China in Beijing, its first dedicated Trent engine facility in China. Management reaffirmed strong 2025 profit and cash flow guidance. Analysts continue to raise their targets.
10 December 2025
·
British American Tobacco (BATS, BTI) Extends £1.3bn Buyback and Reaffirms 2026 Guidance – What It Means for the Stock Now

British American Tobacco (BATS, BTI) Extends £1.3bn Buyback and Reaffirms 2026 Guidance – What It Means for the Stock Now

British American Tobacco shares closed at 4,330p in London and $57.29 in New York on 10 December, both up over 45% year-on-year. The company expects 2025 revenue and profit growth of about 2%, with 2026 guidance at the lower end of its 3–5% revenue growth target. BAT announced a £1.3bn share buyback for 2026 and sold most of its stake in ITC Hotels to reduce debt.
10 December 2025
··
Standard Chartered PLC (LON: STAN) Stock Today: Share Price Near Record High as Buybacks and Digital Asset Push Shape 2026 Outlook

Standard Chartered PLC (LON: STAN) Stock Today: Share Price Near Record High as Buybacks and Digital Asset Push Shape 2026 Outlook

Standard Chartered shares closed at 1,695p on 10 December 2025, near a record high, after continued share buybacks and upgraded earnings guidance. The bank repurchased over 575,000 shares on 9 December as part of a $1.3 billion buyback. Market capitalization stands near £39 billion. Meanwhile, its research arm halved its Bitcoin price forecast.
10 December 2025
·
Barclays PLC Stock on 10 December 2025: Buyback Support, Fintech Deal and 2026 Outlook

Barclays PLC Stock on 10 December 2025: Buyback Support, Fintech Deal and 2026 Outlook

Barclays PLC shares closed at 440.05p in London on 10 December 2025, just below their 52-week high after a 65% gain over the past year. The bank announced a strategic investment in United Fintech, joining four other global banks as investors. Barclays’ recent rally follows a £500m share buyback in October and improved earnings outlook for 2026. Financial terms of the fintech deal were not disclosed.
10 December 2025
····
Best UK Stocks to Buy Now (10 December 2025): 8 FTSE Shares for Growth, Income & Recovery

Best UK Stocks to Buy Now (10 December 2025): 8 FTSE Shares for Growth, Income & Recovery

The FTSE 100 rose yesterday as gains in BAE Systems and Rolls-Royce offset losses in British American Tobacco. Investors are positioning for possible rate cuts in 2026, with UK inflation down to 3.6% in October. The Bank of England expects the upcoming budget to further reduce inflation and says banks remain resilient. FTSE 100 companies are set to repurchase about £56.6bn in stock this year.
10 December 2025
······
UK Stock Market Biggest Gainers Today (10 December 2025): Small-Cap Surge as FirstGroup, Made Tech & ProCook Jump

UK Stock Market Biggest Gainers Today (10 December 2025): Small-Cap Surge as FirstGroup, Made Tech & ProCook Jump

Made Tech Group surged 18.5% after raising full-year guidance on strong H1 results. ProBiotix Health, Bisichi, and Wishbone Gold also posted double-digit gains on earnings and contract news. The FTSE 100 edged up 0.1% to 9,648 in early trade, while the FTSE 250 slipped 0.2% as traders awaited the US Fed’s rate decision. Retail stocks lagged after weak November sales data.
10 December 2025
··············
Most Active UK Stocks Today (10 December 2025): HSBC, BP and Tesco Lead London’s Volume Surge

Most Active UK Stocks Today (10 December 2025): HSBC, BP and Tesco Lead London’s Volume Surge

Lloyds, Vodafone, HSBC, and Barclays led UK trading volumes Wednesday, each moving millions of shares by mid-morning. The FTSE 100 rose 0.2% at 08:30 GMT, while sterling climbed above $1.33. BP, Tesco, and Volution Group also saw heavy activity, with Volution jumping over 7% after a strong update and acquisition news. German and French indices slipped.
10 December 2025
···············
UK Stock Market Today, 10 December 2025: FTSE 100 Steadies as Fed Rate Cut and BoE Signals Take Center Stage

UK Stock Market Today, 10 December 2025: FTSE 100 Steadies as Fed Rate Cut and BoE Signals Take Center Stage

The FTSE 100 edged up about 0.1% near 9,650 on Wednesday, rebounding after three sessions of losses as investors awaited interest-rate decisions from the US Federal Reserve and Bank of England. The FTSE 250 slipped 0.1–0.2%, while broader European markets fell for a fourth day. Wall Street and Asian indices also traded lower ahead of the Fed’s expected rate cut.
10 December 2025
·
FTSE 100 Biggest Losers Today: Sage, Kingfisher, Cohort and Everyman Lead UK Stock Market Declines (10 December 2025)

FTSE 100 Biggest Losers Today: Sage, Kingfisher, Cohort and Everyman Lead UK Stock Market Declines (10 December 2025)

The FTSE 100 edged up 0.1% to 9,647.75 by 08:35 GMT Wednesday, while the FTSE 250 slipped 0.2% as traders awaited a key US Fed rate decision. The Sage Group fell 2.1%, Kingfisher dropped 1.6%, and Ashtead Group lost 1.5% in early trading. Cohort and Everyman Media tumbled among mid- and small-caps following company updates. UK retail sales growth slowed to 1.4% in November.
10 December 2025
·
Unilever PLC (ULVR, UL) Stock Jumps After Magnum Demerger and Share Consolidation – December 2025 Outlook

Unilever PLC (ULVR, UL) Stock Jumps After Magnum Demerger and Share Consolidation – December 2025 Outlook

Unilever shares jumped 16% in Amsterdam and nearly 16% in New York on 10 December 2025, following the €8.6 billion spin-off of Magnum Ice Cream Company and an 8-for-9 share consolidation. CEO Fernando Fernandez pledged higher margins and €1.5 billion annually for acquisitions. Underlying sales rose 3.9% in Q3. Analyst views remain divided.
10 December 2025
··
1 … 493 494 495 496 497 … 587

Stock Market Today

  • Comcast Shares Flat After Confirming $8 Billion UK Universal Theme Park Investment
    June 4, 2026, 6:21 PM EDT. Comcast (NASDAQ:CMCSA) shares were largely unchanged, closing at $23.33, following its announcement of an $8 billion investment to build Universal's first European resort in the United Kingdom. The theme park project is expected to generate over $60 billion in economic activity through 2055. Trading volume was 35% above the three-month average, hitting 44.6 million shares. The stock has faced pressure in 2026, down 22%, with Comcast holding $95 billion in net debt against an $83 billion market cap. Investors are weighing potential long-term growth from the park against leverage concerns. The S&P 500 rose 0.41% while the Nasdaq slipped 0.09%, with mixed results among telecom peers Charter and Verizon.

Latest articles

DocuSign Shares Fall After Earnings Beat, AI Prospects in Focus

DocuSign Shares Fall After Earnings Beat, AI Prospects in Focus

5 June 2026
Docusign shares slid 4.2% after hours to $48.78 as investors shrugged off a Q1 earnings and revenue beat, focusing instead on near-consensus guidance and lingering doubts about the pace of AI-driven growth, despite IAM platform ARR rising to 12.6% and record share buybacks.
Mortgage Rates Drop but Homebuyers Stay on Sidelines

Mortgage Rates Drop but Homebuyers Stay on Sidelines

5 June 2026
U.S. 30-year mortgage rates dipped to 6.48% from 6.53%, but mortgage applications fell 2.5% for the week ended May 29, with purchase demand down 3%, as lower rates failed to revive buyer activity; forecasts see only slow relief ahead, while median home list prices dropped 2.4% in May, the steepest annual decline since 2017.
T1 Energy Stock Touches 52-Week High After $32M Battery Deal Draws AI Investors

T1 Energy Stock Touches 52-Week High After $32M Battery Deal Draws AI Investors

4 June 2026
T1 Energy surged 1.4% to $11.66, hitting a 52-week high after agreeing to buy KORE Power for $32 million, expanding into battery storage and AI data center power; the company expects the deal to boost EBITDA in 2026 and add $15–$20 million in 2027, but closing depends on approvals and faces risks from project delays, supply chain, and clean-energy policy uncertainty.
Merck Stock Gains as Keytruda Concerns Ease, Investors Look to Pipeline Bets

Merck Stock Gains as Keytruda Concerns Ease, Investors Look to Pipeline Bets

4 June 2026
Merck shares surged 4.9% to $120.26 after ASCO data showed its new cancer drug sac-TMT combined with Keytruda improved progression-free survival, reinforcing confidence in Merck’s post-Keytruda pipeline as investors weigh looming patent expirations and competition, with the stock’s rally fueled by optimism but tempered by risks of future trial and regulatory outcomes.
Lululemon Slashes Outlook, Raising Pressure on Incoming CEO

Lululemon Slashes Outlook, Raising Pressure on Incoming CEO

4 June 2026
Lululemon slashed its annual revenue and profit forecasts due to weak U.S. demand, sending shares down about 9% in after-hours trading; the company now expects fiscal 2026 revenue of $11.00–$11.15 billion and EPS of $10.95–$11.15, both below previous guidance, as gross margin fell and U.S. sales dropped despite international growth.
Go toTop